Analgesic effect of nitroglycerin additive to lidocaine in intravenous regional anesthesia
Phase 3
- Conditions
- The intravenous regional anesthesia.Anaesthetics and therapeutic gases
- Registration Number
- IRCT2015072712642N17
- Lead Sponsor
- Vice Chancellor for research of Zahedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
non urgent surgery; age more than 20 years.
Exclusion criteria: Sickle cell anemia; Raynaud's phenomena; history of use of nitroglycerine; history of use of sildenafil in 24 hours ago; history of allergy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient's tourniquet pain. Timepoint: At 5, 10, 15, 20, 40 minutes after the start of operation will be evaluated. Method of measurement: According to VAS score.;Venous oxygen saturation. Timepoint: Before and after use tourniquet. Method of measurement: By pulse oximetry based on mmHg.
- Secondary Outcome Measures
Name Time Method Blood Pressure. Timepoint: Before and after use tourniquet. Method of measurement: By mercury sphygmomanometer based on mmHg.;Heart Rate. Timepoint: Before and after use Tourniquet. Method of measurement: By pulse oximetry based on the number of minutes.